Related Experiment Videos
New targets in oncology drug development
1Erasmus University Medical Center, Rotterdam, The Netherlands.
Clinical Advances in Hematology & Oncology : H&O
|November 1, 2005
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Challenges and Potential Solutions to Advance Global Cancer Drug Development.
Therapeutic innovation & regulatory science·2026
Empowering effective biomarker-driven precision oncology: A call to action.
European journal of cancer (Oxford, England : 1990)·2024
A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation.
Clinical cancer research : an official journal of the American Association for Cancer Research·2021
Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.
Clinical advances in hematology & oncology : H&O·2026
Molecular residual disease (MRD) testing: advancing clinical decision-making in breast cancer.
Clinical advances in hematology & oncology : H&O·2026
Hemophagocytic lymphohistiocytosis: new grading classification and targeted therapies.
Clinical advances in hematology & oncology : H&O·2026
Statistical analysis plan considerations for autologous cell and cell-based gene therapy clinical trials.
Journal of biopharmaceutical statistics·2026
Nanosensitive optical coherence tomography to monitor corneal burn and treatment response in vivo.
Biomedical optics express·2026
Contemporary perspectives on metabolic surgery for type 2 diabetes: surgical techniques, outcomes, and complications.
Frontiers in endocrinology·2026